Bronchitis Flashcards

1
Q

Classifications of bronchitis


A

Acute bronchitis
Chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute Bronchitis

A

Characteristics:
* Swelling of the lining of the trachea and bronchial tree.
* Narrowing of the tubes.
* Increased secretion of inflammatory fluid.

Common Features:
* Occurs following viral (commonly) or bacterial infection.
* Can result from chemical irritation (e.g., cigarette smoking, air pollution, or gastric acid reflux).
* Common in individuals of all ages.
* More prevalent in winter and/or areas with increased irritants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic Bronchitis

A

Definition:
* Daily production of sputum for at least 3 months in 2 consecutive years.

Characteristics:
* Persistent inflammation of the bronchial passages.
* Prolonged and recurring symptoms.
* Often associated with long-term exposure to irritants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Viral Agents Associated with Acute Bronchitis

A
  • Influenza A and B.
  • Respiratory syncytial virus (RSV).
  • Parainfluenza.
  • Adenovirus.
  • Cold viruses (Rhinovirus & Coronavirus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bacterial Pathogens in Acute Bronchitis

A
  • Streptococcus pneumoniae.
  • Moraxella catarrhalis.
  • Haemophilus influenzae.
  • Chlamydia pneumoniae.
  • Mycoplasma pneumoniae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Etiology and Pathophysiology

A
  • Viral infection of trachea and bronchi leads to mucosal inflammatory response.
  • Increased bronchial secretions result in acute bronchitis.
  • Destruction of respiratory mucosa is part of the process
  • Dysfunction impairs clearance and contributes to chronic airway diseases
  • Recurrent or repeated acute respiratory infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiology in children

A
  • Acute airway injury or continuous exposure to environmental agents, allergens, or irritants can lead to bronchospasm and cough.
  • Recurrent aspiration or repeated viral infection increases the risk of chronic infections and lower respiratory tract infections.
  • Children Predisposed to Aspiration:

If protective airway mechanisms are compromised, children may be infected with oral anaerobic strains of streptococci due to oropharyngeal aspiration.

  • Tracheostomies in Children:

Often colonized with flora like α-hemolytic and γ-hemolytic streptococci.

Acute exacerbations may involve pathogens like Pseudomonas aeruginosa and Staphylococcus aureus (including methicillin-resistant strains)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Common Organisms in Children

A
  • Streptococcus pneumoniae.
  • Haemophilus influenzae.
  • Mycoplasma pneumoniae.
  • Moraxella catarrhalis- More prevalent in children aged 6-18 years and preschoolers (age < 5 years)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mucociliary System in Acute Bronchitis

A
  • Mucociliary clearance is the primary defense mechanism.
  • Dysfunction impairs clearance and contributes to chronic airway diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Components of mucociliary system

A
  • Cilia
  • protective mucus layer
  • airway surface liquid (ASL) layer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ASL Dehydration and Chronic Inflammation

A
  • ASL dehydration reduces mucus clearance.
  • Contributes to mucous obstruction, goblet cell hyperplasia, and chronic inflammatory cell infiltration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical presentation of acute bronchitis

A
  • Follows upper respiratory infection.
  • Hallmark: Hacking cough.
  • Nasopharyngeal complaints.
  • Production of clear phlegm, yellow, or green sputum.
  • Fever and N/V/D are rare but can occur
  • Sore throat.
  • Runny or stuffy nose.
  • Headache.
  • Muscle aches.
  • General malaise/fatigue.
  • Chest pain (severe cases).
  • Dyspnea and cyanosis, especially in patients with COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Complications of bronchitis

A
  • Bacterial superinfection
  • Chronic Bronchitis
  • Pneumoniae
  • Hemoptysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Differential Diagnoses

A
  • Asthma
  • Influenza
  • Bronchiolitis
  • Chronic bronchitis (COPD)
    Bronchiectasis
  • Acute or chronic sinusitis
  • Bacterial tracheitis/
    pharyngitis
  • Tonsillitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tests and investigations

A
  1. Full blood count
  2. Sputum cytology
  3. Chest radiography
  4. Bronchoscopy
  5. Spirometry
  6. Blood culture
  7. Troat swab
  8. Respiratory secretion cultures
  9. Procalcitonin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Procalcitonin

A
  • Levels increase in bacterial infections (not in viral or other inflammatory conditions).
  • Values ≥ 0.25 mcg/L (in non-ICU patients) or > 0.5 mcg/L (in ICU patients).

Clinical Use:

  • Indicative for initiation of antibiotic therapy
  • A decrease of at least 80% in levels can be a guide for discontinuing antibiotics.

Antibiotic Usage and Complications:

  • The use of a procalcitonin algorithm may reduce antibiotic usage without increasing the risk of complications
17
Q

Goals of Management

A
  • Alleviate symptoms of acute bronchitis.
  • Correct dehydration.
  • Treat associated respiratory symptoms.
  • Maintain and open obstructed bronchial airways.
  • Thin obstructive mucus to facilitate expectoration.
  • Prevent the development of complications
18
Q

Symptomatic and Supportive care (Non-pharmacological)

A
  • Ensure adequate oxygenation.
  • Increase fluid intake to prevent dehydration.
  • Decrease viscosity of respiratory secretions.
  • Bed rest to relieve lethargy and malaise.
  • Reassurance.
  • Avoidance of environmental irritants, especially cigarette smoke.
19
Q

Medications for management of Acute bronchitis

A
  • Analgesics and antipyretics (e.g., paracetamol, aspirin, ibuprofen) to alleviate symptoms.
  • Inhaled bronchodilators (e.g., salbutamol, terbutaline) for bronchial relaxation.
  • 90-180 mcg (1-2 puffs) inhaled PO q4-6 hours.
  • Inhaled corticosteroids (e.g., beclomethasone, fluticasone, budesonide inhaler).
  • Oral corticosteroids (e.g., prednisolone) for a short course.
  • Dextromethorphan for mild persistent cough.
  • Codeine intermittently for severe cough
20
Q

Antibiotic Therapy

A
  • Routine antibiotic use discouraged.
  • Consider if there is a suboptimal response to supportive intervention or persistent respiratory symptoms with fever.
  • Directed toward respiratory pathogens (e.g., Strep. pneumoniae, H. influenzae, M. pneumoniae).
  • Examples of antibiotics: Macrolides, fluoroquinolones, or beta-lactamase-resistant antimicrobials.
21
Q

Evaluation of Therapy in Acute Bronchitis

A
  • Amelioration of symptoms.
  • Assess to rule out pneumonia and other complications.
  • Treat any complications that arise.
  • Assess the need for antibiotics based on clinical response.
  • Ensure adherence to prescribed medications.
  • Reassure the patient about the natural course of the disease.
  • Encourage avoiding unnecessary antibiotic use